Daewoong’s Enblo Demonstrates Strong Potential to Reverse Fatty Liver in Diabetes Patients
Daewoong Pharmaceutical announced that its newly developed type 2 diabetes medication, Enblo (active ingredient: inavogliflozin), has shown...
Search results for "Phase 3 trial"
AI Trained on 200,000 Patient Records Predicts Early Mortality Risk in Severe Trauma
“Can we save this patient. Should we send them straight to the operating room, or does the intensive care unit come first.
New Non-Invasive MRI Method Visualizes Elusive Liver and Intestinal Lymph Vessels
South Korean researchers have developed a breakthrough MRI technique that images the body’s lymphatic system without an...
United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy
The race to develop regenerative cell therapies for an ultra-rare disease that leaves patients born without a...
ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients
South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor...
Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care
“Lately, I keep forgetting appointments.” “They keep repeating what they just said.” When memory lapses in a parent...
Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco
Waking up frequently at night to urinate or noticing a weaker urine stream is a common health concern for men as they...
Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer
Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its...
Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment
Treatment for inflammatory bowel disease is rapidly moving beyond simple symptom management toward the structural...
Resetting the Body Clock: Smartphone App Cuts Mood Disorder Relapse Rates to One-Third
"I’m taking my medication faithfully—so why is this happening again?" It is a deeply frustrating question that patients...